USANA Health Sciences, Inc. (NYSE:USNA) Director Gilbert A. Fuller Sells 1,058 Shares

Key Points

• USANA Health Sciences Director Gilbert A. Fuller sold 1,058 shares at an average price of $29.10, totaling $30,787.80.
• USANA reported earnings of $0.74 per share for the last quarter, exceeding analysts' expectations of $0.54.
• Analysts upgraded USANA’s stock rating from "hold" to "buy" as of May 22nd, suggesting a positive outlook for the company.

USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) Director Gilbert A. Fuller sold 1,058 shares of the company's stock in a transaction dated Thursday, August 7th. The shares were sold at an average price of $29.10, for a total transaction of $30,787.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

USANA Health Sciences Stock Up 2.9%

USNA stock traded up $0.88 during mid-day trading on Wednesday, hitting $30.95. The company had a trading volume of 6,418 shares, compared to its average volume of 179,501. The company has a 50-day moving average price of $30.82 and a 200 day moving average price of $29.67. The company has a market capitalization of $565.38 million, a price-to-earnings ratio of 17.10, a P/E/G ratio of 0.93 and a beta of 0.61. USANA Health Sciences, Inc. has a 12-month low of $23.10 and a 12-month high of $41.83.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its earnings results on Tuesday, July 22nd. The company reported $0.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.54 by $0.20. The firm had revenue of $235.85 million for the quarter, compared to analysts' expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. As a group, analysts expect that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Hedge Funds Weigh In On USANA Health Sciences

Hedge funds have recently added to or reduced their stakes in the stock. KLP Kapitalforvaltning AS purchased a new stake in USANA Health Sciences during the fourth quarter valued at approximately $83,000. Norges Bank purchased a new stake in USANA Health Sciences during the fourth quarter valued at approximately $953,000. Franklin Resources Inc. lifted its position in USANA Health Sciences by 4.8% during the fourth quarter. Franklin Resources Inc. now owns 22,070 shares of the company's stock valued at $792,000 after acquiring an additional 1,020 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of USANA Health Sciences by 1.6% in the fourth quarter. Geode Capital Management LLC now owns 301,949 shares of the company's stock worth $10,839,000 after buying an additional 4,829 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in USANA Health Sciences during the 4th quarter worth about $206,000. 54.25% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Wall Street Zen raised shares of USANA Health Sciences from a "hold" rating to a "buy" rating in a research report on Thursday, May 22nd.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.